Microbiology
Summary
Trypanosoma cruzi is a protozoan parasite responsible for Chagas disease, which is endemic to Latin America. Transmission predominantly occurs via the triatomine bug, commonly known as the 'kissing bug'. Within this vector and its human host, T. cruzi progresses through its lifecycle, adopting various morphological forms. The amastigote is the replicative form of the parasite, while the trypomastigote is the non-replicating, infective form found circulating in the bloodstream.
Infections frequently initiate in childhood and can also manifest as congenital disease, where the infection is vertically transmitted from mother to child. Initial symptoms in an infected individual might manifest as fever or a unique lesion termed a chagoma. More seriously, congenital Chagas disease presents with low birth weight, anemia, and hepatosplenomegaly. This parasite primarily affects the heart, gastrointestinal tract, and the nervous system and is particularly adept at targeting the myenteric plexus of the GI tract and myocardial tissue. In its chronic phase, which might span an asymptomatic period of 10-30 years, Chagas disease can lead to severe cardiovascular complications such as heart hypertrophy, dilation, heart failure, arrhythmia, thromboembolism, and notable gastrointestinal symptoms. Prevention of the disease hinges on vector control, enhancement of housing conditions, and screening of would-be parents. In terms of treatment, infections by T. cruzi are commonly addressed with medications like benznidazole and nifurtimox.
Lesson Outline
Don't stop here!
Get access to 128 more Microbiology lessons & 13 more medical school learning courses with one subscription!
FAQs
Trypanosoma cruzi is a protozoan parasite that's responsible for causing Chagas disease, which is primarily transmitted through an insect known as the triatomine bug. Chagas disease is especially prevalent in Latin America, where vector transmission is primarily accountable for its spread.
The transmission of Trypanosoma cruzi mostly occurs through contact with the feces of the infected triatomine bug. When the bug bites a person and feeds on their blood, it defecates. The parasite is then unknowingly rubbed into the bite wound or other areas like the eyes or mouth, by the person while they're scratching or touching. However, other transmission modes include congenital transmission, blood transfusion, organ transplantation, and consumption of contaminated food or drink.
Trypanosoma cruzi exists in different forms in its life cycle. Two major forms are the amastigote and the trypomastigote. The amastigote is the replicative form that lives inside host cells. When amastigotes multiply and the host cell ruptures, they transform into trypomastigotes, which then invade other cells or are taken up by a triatomine bug when it feeds on the infected host's blood.
Chagas disease is highly prevalent in Latin America due to the widespread population of the triatomine bug in these areas and socio-economic conditions that facilitate the transmission of the disease. It's estimated that 6-7 million people worldwide are infected with Trypanosoma cruzi, most of them in Latin America. However, due to international migration, Chagas disease is increasingly found in the United States, Canada, and Europe.
Currently, the primary treatments for Chagas disease are two anti-parasitic drugs benznidazole and nifurtimox; however, the effectiveness of these drugs decreases the longer a person has been infected. They are most effective when given early in the course of infection. In the chronic phase, treatment may involve managing the clinical symptoms of the disease, such as treating cardiac or digestive complications.
